BESREMI Trademark

Trademark Overview

On Wednesday, May 20, 2015, a trademark application was filed for BESREMI with the United States Patent and Trademark Office. The USPTO has given the BESREMI trademark a serial number of 79168468. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, June 28, 2022. This trademark is owned by AOP Orphan Pharmaceuticals AG. The BESREMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, antineoplastic and immunomodulating agents
besremi

General Information

Serial Number79168468
Word MarkBESREMI
Filing DateWednesday, May 20, 2015
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, June 28, 2022
Registration Number4896895
Registration DateTuesday, February 9, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, antineoplastic and immunomodulating agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 10, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePHARMAESSENTIA CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressTaipei City 115 115603
CN
Party NameAOP Orphan Pharmaceuticals AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAT
Party NameAOP Orphan Pharmaceuticals AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAT
Party NameAOP Orphan Pharmaceuticals AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events

Event DateEvent Description
Tuesday, June 28, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, June 28, 2022REGISTERED-SEC.71 ACCEPTED
Wednesday, June 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 18, 2022TEAS SECTION 71 RECEIVED
Tuesday, February 9, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, November 19, 2018CHANGE OF OWNER RECEIVED FROM IB
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 11, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 11, 2016FINAL DISPOSITION PROCESSED
Monday, May 9, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 9, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, November 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2015PUBLISHED FOR OPPOSITION
Friday, November 20, 2015NOTIFICATION PROCESSED BY IB
Wednesday, November 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 4, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 13, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 13, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 6, 2015ASSIGNED TO LIE
Friday, September 18, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 18, 2015REFUSAL PROCESSED BY IB
Wednesday, September 2, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 2, 2015REFUSAL PROCESSED BY MPU
Wednesday, September 2, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 1, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 1, 2015ASSIGNED TO EXAMINER
Tuesday, July 14, 2015APPLICATION FILING RECEIPT MAILED
Friday, July 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 9, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

besremi immunomodulating agents antineoplastic namely preparations pharmaceutical